Published:
Last updated:
see protocol
ID
NL-OMON38893
Source
ToetsingOnline
Brief title
Improve medication adherence after TIA
Condition
- Central nervous system vascular disorders
Synonym
TIA
Research involving
Human
Sponsors and support
Primary sponsor
:
HagaZiekenhuis
Source(s) of monetary or material Support
:
HagaZiekenhuis
Intervention
Keyword
:
CVA, Medication adherence, TIA, vasculair
Outcome measures
Primary outcome
see protocol
Secondary outcome
see protocol
Background summary
see protocol
Study objective
see protocol
Study design
see protocol
Intervention
see protocol
Study burden and risks
see protocol
Public
HagaZiekenhuis
Leyweg 275
Den haag 2566
NL
Leyweg 275
Den haag 2566
NL
Scientific
HagaZiekenhuis
Leyweg 275
Den haag 2566
NL
Leyweg 275
Den haag 2566
NL
Listed location countries
Netherlands
Age
Adults (18-64 years)
Elderly (65 years and older)
Inclusion criteria
patients
1. are referred for TIA screening and gain the diagnosis TIA, which is confirmed by the neurologist. The diagnosis of TIA is determined on the basis of history, physical / neurological examination, MRI, Duplex, ECG and blood tests.
2. Speak and understand the Dutch language
3. Are 18 years or older
4. Are mentally and/or physically able to participate in the study
Exclusion criteria
Patients receiving oral anticoagulant
Design
Study type
:
Interventional
Intervention model
:
Parallel
Allocation
:
Randomized controlled trial
Masking
:
Single blinded (masking used)
Control
:
Active
Primary purpose
:
Prevention
Recruitment
NL
Recruitment status
:
Recruitment stopped
Start date (anticipated)
:
Enrollment
:
150
Type
:
Actual
Approved WMO
Date
:
Application type
:
First submission
Review commission
:
METC Leiden-Den Haag-Delft (Leiden)
metc-ldd@lumc.nl
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL43609.098.13 |